Ranked 3 of 20
Crush Research
Wide catalog with roughly two hundred published reports and endotoxin panels on almost everything.
Overall score
90.4
Strong. Board median 81.7.
Score breakdown
-
Purity
40% weight87.4
6 of 7 samples passed
-
Trust
25% weight96
6 of 7 checks earned in full
-
Delivery
20% weight82
3 business day median
-
Value
15% weight100
0.59x the market median per mg
Transparency checks
Each check is worth a fixed number of points. Together they make up the trust score of 96.
- Certificates readable before checkout 20 / 20
- Lot on certificate matches the vial 20 / 20
- Testing lab named 12 / 12
- Certificate verifies at the lab 13 / 13
- Mass spec identity confirmation 10 / 10
- Trading history (3 years) 6 / 10
- No public enforcement actions 15 / 15
Facts
- Headquarters
- Not disclosed
- Ships from
- United States
- Trading since
- 2023
- Payments
- Cards, Crypto
- Delivery
- 3 business day median
- Carriers
- USPS, UPS. Free over $150
- Testing labs
- Janoshik Analytical, MZ Biolabs
What stands out
- Endotoxin panels on nearly the whole catalog
- Broad product range
Where it falls short
- Address not published
- Price per milligram sits above the board median
Product by product
Rank is this vendor’s position, by overall score, among the vendors with independent results for that compound. Purity and pass counts are for the compound alone. Price is the listed vial normalised to dollars per milligram.
| Product | Avg purity | Passed | Price | Rank |
|---|---|---|---|---|
| Tirzepatide Latest Aug 26, 2026 | 99.67% | 1 / 1 | $2.45/mg $49 / 20 mg , as Double Agonist 20mg Buy | 2 of 12 |
| BPC-157 Latest Jul 11, 2026 | 99.59% | 1 / 1 | $3.50/mg $35 / 10 mg Buy | 3 of 20 |
| GHK-Cu Latest Apr 20, 2026 | 99.77% | 1 / 1 | $0.58/mg $29 / 50 mg Buy | 3 of 15 |
| NAD+ Latest Mar 3, 2026 | 99.20% | 0 / 1 | $0.10/mg $49 / 500 mg Buy | 3 of 8 |
| PT-141 Latest Jan 16, 2026 | 99.70% | 1 / 1 | $3.90/mg $39 / 10 mg Buy | 3 of 8 |
| Retatrutide Latest Oct 9, 2026 | 99.70% | 1 / 1 | $4.90/mg $49 / 10 mg , as Triple Agonist 10mg Buy | 3 of 14 |
| TB-500 Latest May 30, 2026 | 99.61% | 1 / 1 | $5.80/mg $29 / 5 mg Buy | 3 of 13 |
| Cagrilintide Listed, not yet tested | n/a | 0 | $7.00/mg $35 / 5 mg Buy | unranked |
| Ipamorelin Listed, not yet tested | n/a | 0 | $2.20/mg $22 / 10 mg Buy | unranked |
| Semaglutide Listed, not yet tested | n/a | 0 | $2.90/mg $29 / 10 mg , as Single Agonist 10mg Buy | unranked |
| Tesamorelin Listed, not yet tested | n/a | 0 | $4.90/mg $49 / 10 mg Buy | unranked |
- Tirzepatide 2 of 12
1 of 1 passed, $2.45/mg , as Double Agonist 20mg
Buy Double Agonist 20mg - BPC-157 3 of 20
1 of 1 passed, $3.50/mg
Buy BPC-157 - GHK-Cu 3 of 15
1 of 1 passed, $0.58/mg
Buy GHK-Cu - NAD+ 3 of 8
0 of 1 passed, $0.10/mg
Buy NAD+ - PT-141 3 of 8
1 of 1 passed, $3.90/mg
Buy PT-141 - Retatrutide 3 of 14
1 of 1 passed, $4.90/mg , as Triple Agonist 10mg
Buy Triple Agonist 10mg - TB-500 3 of 13
1 of 1 passed, $5.80/mg
Buy TB-500 - Cagrilintide unranked
0 of 0 passed, $7.00/mg
Buy Cagrilintide - Ipamorelin unranked
0 of 0 passed, $2.20/mg
Buy Ipamorelin - Semaglutide unranked
0 of 0 passed, $2.90/mg , as Single Agonist 10mg
Buy Single Agonist 10mg - Tesamorelin unranked
0 of 0 passed, $4.90/mg
Buy Tesamorelin
Test history
Every independent result we hold for Crush Research, newest first. Fill is the measured quantity as a share of the label claim.
- Retatrutide Janoshik Analytical Pass
- Tirzepatide MZ Biolabs Pass
- BPC-157 Janoshik Analytical Pass
- TB-500 MZ Biolabs Pass
- GHK-Cu Janoshik Analytical Pass
- NAD+ MZ Biolabs Purity below 99.5%
- PT-141 Janoshik Analytical Pass